Javara, Winston-Salem research company, raises over $40 million in Series B funding

This newest fundraise demonstrates a significant increase in fundraising for Javara, a Winston-Salem integrated research organization, as it had raised a total of $13 million prior to this Series B raise. Founder and CEO Jennifer Byrne said she is committed to keeping the company in Winston-Salem.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news